Page 1 | Search Results | Blood | American Society of Hematology

1-15 of 15

Sort by

Sort Order Select

Journal Articles

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

Robert N Lown, MD, Steven GE Marsh, PhD, Helen Blake, BSc, Sergio Querol, MD, PhD, Irina Evseeva, PhD, Stephen Mackinnon, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, J. Alejandro Madrigal, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath

Blood (2013) 122 (21): 2138.

https://doi.org/10.1182/blood.V122.21.2138.2138

Published: 2013

Journal Articles

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

John A Snowden, MD, FRCP, FRCPath, Robert Danby, MRCP, Annalisa Ruggeri, MD, David I Marks, Rachael E Hough, MD, Antonio Pagliuca, Michael Potter, MD PhD, Nigel Russell, MD, Charles Craddock, MD DPhil, Andrew Clark, Eliane Gluckman, MD, Gordon Cook, MD, PhD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Vanderson Rocha, MD, PhD

Blood (2013) 122 (21): 3394.

https://doi.org/10.1182/blood.V122.21.3394.3394

Published: 2013

Journal Articles

The ATRA Question In AML: Lack Of Benefit Overall Or In Any Molecular Subgroup In The NCRI AML16 Trial

Alan K. Burnett, MD, Robert K. Hills, MA, MSc, DPhil, Lone S. Friis, MD, PhD, Lars Kjeldsen, MD, PhD, Donald Milligan, MD, FRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Michelle Lazenby, Amanda F Gilkes, MSc, David Bowen, MD, PhD, Nigel Russell, MD

Blood (2013) 122 (21): 493.

https://doi.org/10.1182/blood.V122.21.493.493

Published: 2013

Journal Articles

Lenalidomide Combined With Cyclophosphamide and Dexamethasone Is Effective and Well Tolerated Induction Treatment For Newly Diagnosed Myeloma Patients Of All Ages

Charlotte Pawlyn, MD, Annamaria Brioli, MD, Walter Gregory, PhD, Samantha Hinsley, MSc, Jindriska Lindsay, MD, Gordon Cook, MD, PhD, Donald Milligan, MD, Claire Chapman, MD, Roger G Owen, MD, Mark T Drayson, MD PhD, Nigel Russell, MD, Graham H Jackson, MD, Faith E Davies, MD, Gareth J Morgan, MD PhD

Blood (2013) 122 (21): 540.

https://doi.org/10.1182/blood.V122.21.540.540

Published: 2013

Journal Articles

AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial

Alan K. Burnett, MD, David Bowen, MD, PhD, Nigel Russell, MD, Steven Knapper, MD, Donald Milligan, MD, FRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Asim Khwaja, FRCPath, Richard E. Clark, MBBS, MD, FRCP, FRCPath, Dominic Culligan, Helen Clark, Robert K. Hills, MA, MSc, DPhil

Blood (2013) 122 (21): 622.

https://doi.org/10.1182/blood.V122.21.622.622

Published: 2013

Journal Articles

Reasons For Survival Improvement In Core Binding Factor AML: A 25 Year Analysis Of The UK MRC/NCRI AML Trials

Alan K. Burnett, MD, Robert K. Hills, MA, MSc, DPhil, Nigel Russell, MD, Donald Milligan, MD, FRCP, FRCPath, Ann E. Hunter, MBBS, FRCP, FRCPath, Richard E. Clark, MBBS, MD, FRCP, FRCPath, David Bowen, MD, PhD, Mary Frances McMullin, MD

Blood (2013) 122 (21): 358.

https://doi.org/10.1182/blood.V122.21.358.358

Published: 2013

Journal Articles

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

Rachael E Hough, MD, Bronwen E. Shaw, MBChB, MRCP, PhD, FRCPath, Pip Patrick, Nigel Russell, MD, Antonio Pagliuca, MBBS, FRCP, FRCPath, MA, Charles F. Craddock, BM, MRCP, MRCPath, Eleni Tholouli, Gordon Cook, MD, PhD, David I Marks

Blood (2013) 122 (21): 300.

https://doi.org/10.1182/blood.V122.21.300.300

Published: 2013

Journal Articles

Polymorphisms in Detoxification and DNA Repair Genes in Myelodysplastic Syndromes.

Claire H. Seedhouse, PhD, Stephanie Fischer, MD, Ulrich Germing, MD, Nigel Russell, MD, Detlef Haase, MD

Blood (2007) 110 (11): 2440.

https://doi.org/10.1182/blood.V110.11.2440.2440

Published: 2007

Journal Articles

Interactions of Midostaurin (PKC412), Rapamycin and Ara-C in AML Cell Lines: Role of FLT3 Signalling.

Claire H. Seedhouse, PhD, Shili Shang, MSc, Nigel Russell, MD, Emma Das-Gupta, MD

Blood (2007) 110 (11): 2841.

https://doi.org/10.1182/blood.V110.11.2841.2841

Published: 2007

Journal Articles

A Role for DNA Double Strand Breaks in the Sensitivity of AML Cells to Clofarabine: Enhanced In Vitro Sensitivity in Primary AML Cells with FLT3 Mutations.

Monica Pallis, PhD, Martin Grundy, BSc, Claire Seedhouse, PhD, Heather Pimblett, B Med Sci, Nigel Russell, MD

Blood (2006) 108 (11): 2582.

https://doi.org/10.1182/blood.V108.11.2582.2582

Published: 2006

Journal Articles

Increasing FLT3-ITD Length Increases Expression of bcl-xl in AML.

Claire H. Seedhouse, PhD, Monica Pallis, PhD, Martin Grundy, BSc, Nigel Russell, MD

Blood (2006) 108 (11): 1909.

https://doi.org/10.1182/blood.V108.11.1909.1909

Published: 2006

Journal Articles

Competing Influences of Genetic and Leukaemia-Specific Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the NCRN AML14 and 15 Trials.

Claire H. Seedhouse, PhD, Martin Grundy, BSc, Paul White, PhD, Yun Li, MSc, Janet Fisher, BSc, Darya Yakunina, MD, Anthony Moorman, PhD, Nigel Russell, MD, Alan Burnett, MD, Monica Pallis, PhD

Blood (2006) 108 (11): 835.

https://doi.org/10.1182/blood.V108.11.835.835

Published: 2006

Journal Articles

De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing.

Ronjon Chakraverty, MD, Maria Dimopoulou, MD, Julie Glanville, MD, Kirsty Thomson, MD, Karl Peggs, MD, Donald Milligan, MD, Gordon Cook, MD, Graham Jackson, MD, Anne Parker, MD, Ann Hunter, MD, Nigel Russell, MD, Rachel Pearce, Stephen Mackinnon, MD

Blood (2006) 108 (11): 2901.

https://doi.org/10.1182/blood.V108.11.2901.2901

Published: 2006

Journal Articles

P-Glycoprotein Overexpresion and Internal Tandem Duplications of FLT3 Are Characteristic of Discrete Populations of Elderly AML Patients.

Monica Pallis, PhD, Louise Truran, B Sc, Martin Grundy, B Sc, Janet Fisher, M Sc, Robert Hills, PhD, Keith Wheatley, PhD, Nigel Russell, MD, Alan Burnett, MD

Blood (2004) 104 (11): 196.

https://doi.org/10.1182/blood.V104.11.196.196

Published: 2004

Journal Articles

A Phase 2 Evaluation of Single Agent Clofarabine as First Line Treatment for Older Patients with AML Who Are Not Considered Fit for Intensive Chemotherapy.

Alan K. Burnett, MD, Nigel Russell, MD, Jonathan W. Kell, MD, Donald Milligan, MD, Dominic Culligan, MD

Blood (2004) 104 (11): 869.

https://doi.org/10.1182/blood.V104.11.869.869

Published: 2004

NARROW

Equality Of Access To Transplant For Ethnic Minority Patients Through Use Of Cord Blood and Haploidentical Transplants

Unrelated Cord Blood Transplantation (UCBT) In Adults In The UK: Evolution, Experience and Outcomes. A Retrospective Analysis On Behalf Of The British Society of Blood and Marrow Transplantation (BSBMT) and Eurocord

The ATRA Question In AML: Lack Of Benefit Overall Or In Any Molecular Subgroup In The NCRI AML16 Trial

Lenalidomide Combined With Cyclophosphamide and Dexamethasone Is Effective and Well Tolerated Induction Treatment For Newly Diagnosed Myeloma Patients Of All Ages

AC220 (Quizartinib) Can Be Safely Combined With Conventional Chemotherapy In Older Patients With Newly Diagnosed Acute Myeloid Leukaemia: Experience From The AML18 Pilot Trial

Reasons For Survival Improvement In Core Binding Factor AML: A 25 Year Analysis Of The UK MRC/NCRI AML Trials

Early Multilineage Chimerism Predicts The ‘Winning’ Unit In Double Cord Blood Transplantation

Polymorphisms in Detoxification and DNA Repair Genes in Myelodysplastic Syndromes.

Interactions of Midostaurin (PKC412), Rapamycin and Ara-C in AML Cell Lines: Role of FLT3 Signalling.

A Role for DNA Double Strand Breaks in the Sensitivity of AML Cells to Clofarabine: Enhanced In Vitro Sensitivity in Primary AML Cells with FLT3 Mutations.

Increasing FLT3-ITD Length Increases Expression of bcl-xl in AML.

Competing Influences of Genetic and Leukaemia-Specific Factors on P-Glycoprotein Expression in Blasts from 817 Patients Entered into the NCRN AML14 and 15 Trials.

De-Escalation of the Alemtuzumab Dose Prior to Nonmyeloablative HLA-Identical Sibling Transplantation: Crucial Role of Timing.

P-Glycoprotein Overexpresion and Internal Tandem Duplications of FLT3 Are Characteristic of Discrete Populations of Elderly AML Patients.

A Phase 2 Evaluation of Single Agent Clofarabine as First Line Treatment for Older Patients with AML Who Are Not Considered Fit for Intensive Chemotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only